Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes (Q84729217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Shufa Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Min Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Fei Xiang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jianyong Zhao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Chao Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jinkun Zhu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

7 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

7747-7751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

Insulin-dependent diabetes mellitus

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Islet transplantation for diabetes: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

CD8+ T cells in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Skewed T-cell receptor usage and junctional heterogeneity among isletitis alpha beta and gamma delta T-cells in human IDDM [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Organization of proximal signal initiation at the TCR:CD3 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Models of antigen receptor activation in the design of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Cutting edge: A critical role of B and T lymphocyte attenuator in peripheral T cell tolerance induction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Unconventional ligand activation of herpesvirus entry mediator signals cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Therapy with GAD in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Gene therapy in type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Autoantibodies in type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

T cells in the pathogenesis of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Achieving antigen-specific tolerance in diabetes: regulating specifically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

The role of positive costimulatory molecules in transplantation and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Inhibitory costimulation and anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

T-cell tolerance or function is determined by combinatorial costimulatory signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

BTLA and HVEM cross talk regulates inhibition and costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.125

10.1016/J.VACCINE.2011.07.125

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827810%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference